Sitemap - 2025 - Provectus’s Substack

Two Golden Rules. One Uncommon Path.

Understanding Rose Bengal Sodium: Biotech Blind Spots and Systems Thinking

Reprogramming the Code of Disease: Why Provectus’s Small Molecule Rose Bengal Sodium May Act Like a Biological Operating System

Do Immune Checkpoint Inhibitors Truly Deserve the Label “Immunotherapy?”

“What the Market Can Bear:” Drug Pricing, Capital Discipline, and the Case for a Smarter Biotech Model

From Snake Oil to Systems Reprogrammer: What Tennessee Taught Rose Bengal

Health Tech: Edward Pershing Of VisiRose On How Their Technology Can Make An Important Impact On Our Overall Wellness

Timing vs. Biology: The Era of Rose Bengal Sodium-based Medicines Will Be System-Aware, Not Schedule-Bound

From Survive to Strategize: The Two Eras of Capital Raising at Provectus Biopharmaceuticals (PVCT)

VisiRose: Blocking and Tackling

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts